21.10
2021
Testmate Health has successfully closed an oversubscribed seed round of 1.62 million CHF
Testmate Health has successfully closed an oversubscribed seed round of 1.62 million CHF, with the first closing occurring earlier this spring and the round extended to bring in U.S. based & women's health focused VC
Rhia Ventures. In addition to
Rhia Ventures, Testmate Health also welcome the fund Next Ventures for Humanity alongside a host of wonderful angels.
Testmate Health also welcome
Thomas Zehnder onto our Board of Directors and
Elizabeth Bailey as Board Observer. With their deep MedTech industry expertise across both sides of the Atlantic, they will guide Testmate Health through the next stages.
With the funds, Testmate Health plans to accelerate product development & complete pre-clinical studies of their device.